NEW ORLEANS — Transcatheter aortic valve replacement (TAVR) using the SAPIEN 3 system (Edwards Lifesciences) showed a significantly lower rate of the primary endpoint, a composite of death, stroke, ...

Dr. Susheel Kodali kept his gaze fixed on the four monitors suspended above the patient he was operating on at NewYork-Presbyterian/Columbia University Medical Center's Heart Valve Center. "You see, ...

In the United States, cardiovascular health is especially important. Heart disease is the leading cause of death in the U.S., and as many as 1.5 million people have been diagnosed with aortic stenosis ...

Just days ahead of a Centers for Medicare & Medicaid Services (CMS) meeting addressing procedural volume and other requirements for hospitals offering transcatheter aortic valve procedures, a few ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Transcatheter aortic valve replacement, or TAVR, is a minimally invasive heart procedure that replaces a thickened aortic valve that can't fully open (aortic stenosis). The procedure restores proper ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that involves replacing the aortic valve in people with aortic stenosis. It has several benefits over open heart surgery ...

SAN ANTONIO -- The early experience of patients needing cardiac surgery after transcatheter aortic valve replacement (TAVR) has surgeons raising the alarm about the excess risks of these challenging ...

Please provide your email address to receive an email when new articles are posted on . The benefit of TAVR vs. clinical surveillance for patients with asymptomatic severe aortic stenosis did not vary ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- The ...

SAN FRANCISCO — After 7 years, transcatheter aortic valve replacement (TAVR) remains equivalent to surgery with respect to durability and safety in low-risk patients, a finding that may blunt ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. At 7 years, there was no difference in clinical outcomes ...